Warburg to buy minority stake in medical devices major Meril for $210 mn

Warburg Pincus has agreed to pick up a minority stake for $210 million (about Rs 1,575 crore) in Micro Life Sciences, the parent firm of the Meril Group

Meril life sciences
Press Trust of India Mumbai
2 min read Last Updated : Feb 22 2022 | 3:20 PM IST

Leading global growth investor Warburg Pincus has agreed to pick up a minority stake for USD 210 million (about Rs 1,575 crore) in Micro Life Sciences, the parent firm of the Meril Group, which is the largest medical devices firm in the country.

Warburg said the transaction, awaiting CCI approval, will be carried out through its affiliate South Elm Investments.

Founded by the Bilakhia family, Meril is a fast-growing medical devices firm that designs, manufactures and distributes clinically relevant and state-of-the-art medical devices.

With R&D facilities, manufacturing capability, distribution reach, Meril has market leading position across several categories.

Narendra Ostawal of Warburg Pincus India said he is excited by Meril's compelling growth story and believes it stands to benefit from the secular tailwinds of healthcare in the country.

Sanjeev Bhatt of Meril said this investment establishes high degree of credibility to the domestic medical devices in the global landscape and will help them deepen their international presence, attract global talent, and scale up clinical research efforts.

Meril offers a diversified product portfolio with over 100 technologies in five therapy areas cardiovascular including structural heart devices, orthopedic implants, endo-surgery, surgical robotics and in-vitro diagnostics. It employs over 4,000 employees and has business in over 100 countries and has subsidiaries in the US, Germany, Brazil, Russia, South Africa, Bangladesh, Turkey, China and Japan.

Warburg has over USD 73 billion in private equity assets under management across a portfolio of over 235 companies. Since its founding in 1966 in New York, Warburg has raised 20 private equity funds and two real estate funds, which have invested over USD 100 billion in over 1,000 companies across 40 countries.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Meril Life SciencesWarburg Pincus

First Published: Feb 22 2022 | 3:20 PM IST

Next Story